BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 31182833)

  • 1. HIV infection and coronary heart disease: mechanisms and management.
    Hsue PY; Waters DD
    Nat Rev Cardiol; 2019 Dec; 16(12):745-759. PubMed ID: 31182833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global Context.
    Ntsekhe M; Baker JV
    Circulation; 2023 Jan; 147(1):83-100. PubMed ID: 36576956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does antiretroviral therapy increase or decrease the risk of cardiovascular disease?
    Fichtenbaum CJ
    Curr HIV/AIDS Rep; 2010 May; 7(2):92-8. PubMed ID: 20425563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of coronary heart disease in patients with human immunodeficiency virus.
    Triant VA
    Rev Cardiovasc Med; 2014; 15 Suppl 1(0 1):S1-8. PubMed ID: 24987859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.
    Jaworowski A; Hearps AC; Angelovich TA; Hoy JF
    Front Immunol; 2019; 10():1378. PubMed ID: 31275317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV and coronary heart disease: time for a better understanding.
    Boccara F; Lang S; Meuleman C; Ederhy S; Mary-Krause M; Costagliola D; Capeau J; Cohen A
    J Am Coll Cardiol; 2013 Feb; 61(5):511-23. PubMed ID: 23369416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary heart disease in HIV-infected patients.
    Glesby MJ
    Curr HIV/AIDS Rep; 2005 Jun; 2(2):68-73. PubMed ID: 16091251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Complications of HIV in Endemic Countries.
    Feinstein MJ; Bogorodskaya M; Bloomfield GS; Vedanthan R; Siedner MJ; Kwan GF; Longenecker CT
    Curr Cardiol Rep; 2016 Nov; 18(11):113. PubMed ID: 27730474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and management of cardiovascular disease in patients with HIV.
    Nou E; Lo J; Hadigan C; Grinspoon SK
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):598-610. PubMed ID: 26873066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection and coronary heart disease: an intersection of epidemics.
    Triant VA
    J Infect Dis; 2012 Jun; 205 Suppl 3(Suppl 3):S355-61. PubMed ID: 22577208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease.
    Barnes RP; Lacson JC; Bahrami H
    Curr Atheroscler Rep; 2017 May; 19(5):20. PubMed ID: 28315199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries.
    Lang S; Boccara F; Mary-Krause M; Cohen A
    Arch Cardiovasc Dis; 2015 Mar; 108(3):206-15. PubMed ID: 25725995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus and atherosclerosis.
    Farrugia PM; Lucariello R; Coppola JT
    Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery disease in patients with HIV infection.
    Patel AA; Budoff MJ
    Am J Cardiovasc Drugs; 2015 Apr; 15(2):81-7. PubMed ID: 25672641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.
    Feinstein MJ; Hsue PY; Benjamin LA; Bloomfield GS; Currier JS; Freiberg MS; Grinspoon SK; Levin J; Longenecker CT; Post WS
    Circulation; 2019 Jul; 140(2):e98-e124. PubMed ID: 31154814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-traditional risk factors for atherosclerotic disease: A review for emergency physicians.
    Long A; Long B; Koyfman A
    Am J Emerg Med; 2018 Mar; 36(3):494-497. PubMed ID: 29269163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral molecules and cardiovascular diseases.
    Gibellini D; Borderi M; Clò A; Morini S; Miserocchi A; Bon I; Re MC
    New Microbiol; 2012 Oct; 35(4):359-75. PubMed ID: 23109004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of coronary heart disease in patients with HIV infection.
    Zanni MV; Schouten J; Grinspoon SK; Reiss P
    Nat Rev Cardiol; 2014 Dec; 11(12):728-41. PubMed ID: 25331088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures.
    De Lorenzo F; Collot-Teixeira S; Boffito M; Feher M; Gazzard B; McGregor JL
    Curr Med Chem; 2008; 15(28):2991-9. PubMed ID: 19075647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What happens to cardiovascular system behind the undetectable level of HIV viremia?
    d'Ettorre G; Ceccarelli G; Pavone P; Vittozzi P; De Girolamo G; Schietroma I; Serafino S; Giustini N; Vullo V
    AIDS Res Ther; 2016; 13():21. PubMed ID: 27127532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.